Flash Therapeutics. Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
16
- Investments
-
1
Flash Therapeutics. General Information
Description
Manufacturer of gene transfer tools designed to develop cellular and animal models for validating candidate genes and drug screening. The company produces highly concentrated and purified viral vectors and develops predictive experimental cellular models and genetically modified animals using its patented non-integrative technology and integrative lentiviral vectors.
Contact Information
Website
rnalead.comCorporate Office
- 3 Avenue Hubert Curien
- Centre d Innovation Langlade
- 31100 Toulouse
- France
Corporate Office
- 3 Avenue Hubert Curien
- Centre d Innovation Langlade
- 31100 Toulouse
- France
Flash Therapeutics. Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Flash Therapeutics. Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Flash Therapeutics. Patents
Flash Therapeutics. Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023316015-A1 | Use of apelin for the treatment of lymphedema | Pending | 25-Jul-2022 | ||
| EP-4561605-A1 | Use of apelin for the treatment of lymphedema | Pending | 25-Jul-2022 | ||
| US-20260041732-A1 | Use of apelin for the treatment of lymphedema | Pending | 25-Jul-2022 | ||
| WO-2024023034-A1 | Use of apelin for the treatment of lymphedema | Inactive | 25-Jul-2022 | ||
| AU-2017263137-A1 | Particle for the encapsidation of a genome engineering system | Active | 13-May-2016 | C12N15/86 |
Flash Therapeutics. Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Flash Therapeutics. Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Flash Therapeutics. Investments (1)
Flash Therapeutics.’s most recent deal was a Buyout/LBO with FlashCell. The deal was made on 16-May-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| FlashCell | 16-May-2018 | Buyout/LBO | Drug Delivery |
Flash Therapeutics. Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| FlashCell | Toulouse, France | 2016 |
Flash Therapeutics. FAQs
-
When was Flash Therapeutics. founded?
Flash Therapeutics. was founded in 2005.
-
Where is Flash Therapeutics. headquartered?
Flash Therapeutics. is headquartered in Toulouse, France.
-
What is the size of Flash Therapeutics.?
Flash Therapeutics. has 22 total employees.
-
What industry is Flash Therapeutics. in?
Flash Therapeutics.’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Flash Therapeutics. a private or public company?
Flash Therapeutics. is a Private company.
-
What is Flash Therapeutics.’s current revenue?
The current revenue for Flash Therapeutics. is .
-
How much funding has Flash Therapeutics. raised over time?
Flash Therapeutics. has raised $24.8M.
-
Who are Flash Therapeutics.’s investors?
Enthéos, Enowe, Otium Capital, Techlife Capital, and Auriga Partners (Paris) are 5 of 15 investors who have invested in Flash Therapeutics..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
